The role of survivin2 in primitive hematopoiesis during zebrafish development

被引:15
作者
Ach Ma [1 ]
Mis Chung [1 ]
Liang, R. [1 ]
Ayh Leung [1 ]
机构
[1] Univ Hong Kong, Dept Med, Queen Mary Hosp, Div Haematol & Bone Marrow Transplantat, Hong Kong, Hong Kong, Peoples R China
关键词
surviving; primitive hematopoiesis; zebrafish embryos; apoptosis; ANTI-APOPTOSIS GENE; CELL-DIVISION; CANCER; REQUIREMENTS; EXPRESSION; EVOLUTION;
D O I
10.1038/leu.2008.363
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Survivin is an inhibitor of apoptosis and its role in embryonic development is not completely understood. In zebrafish, survivin undergoes gene duplication. Survivin1 (sur1) has been shown to mediate angiogenesis but not hematopoiesis. In this study, we examined survivin2 (sur2) with particular reference to its role in primitive hematopoiesis during zebrafish development. sur2 was expressed predominantly in the intermediate cell mass (ICM, site of primitive hematopoiesis). Morpholino (MO) targeting at intron1-exon2 junction of sur2 significantly reduced green fluorescent protein(+) (erythroid) cell population in transgenic Tg (gata1:gfp) embryos at 18 h post-fertilization (h.p.f.; wild type: 4.49 +/- 0.15%; Sur2(MO) embryos: 2.22 +/- 0.12%, P = 0.02). Molecular targeting was confirmed by reverse transcription-PCR and MO specificity by successful sur2 mRNA rescue. sur2 MO also downregulated genes associated with hematopoietic stem cells (scl, lmo2), erythroid (gata1, a-and beta-embryonic hemoglobins) as well as early (pu.1) and late (mpo, l-plastin) myelomonocytic lineages at 12 and 18 h.p.f. This was associated with an increase in apoptosis in the ICM and alteration of cell-cycle status of erythroid cells. Both effects were caspase dependent. In conclusion, sur2 is important in maintaining hematopoietic stem and lineage committed cells during zebrafish development, by virtue of its antiapoptotic activity in a caspase dependent and cell autonomous fashion.
引用
收藏
页码:712 / 720
页数:9
相关论文
共 26 条
[1]
Adida C, 1998, AM J PATHOL, V152, P43
[2]
Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[3]
Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm [J].
Altieri, DC .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 92 (04) :656-663
[4]
Survivin, versatile modulation of cell division and apoptosis in cancer [J].
Altieri, DC .
ONCOGENE, 2003, 22 (53) :8581-8589
[5]
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[6]
Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer? [J].
de Graaf, AO ;
de Witte, T ;
Jansen, JH .
LEUKEMIA, 2004, 18 (11) :1751-1759
[7]
Survivin increased vascular development during Xenopus ontogenesis [J].
Du Pasquier, David ;
Phung, Albert Chesneau ;
Ymlahi-Ouazzani, Qods ;
Sinzelle, Ludivine ;
Ballagny, Chantal ;
Bronchain, Odile ;
Du Pasquier, Louis ;
Mazabraud, Andre .
DIFFERENTIATION, 2006, 74 (05) :244-253
[8]
Delineation of the cell-extrinsic apoptosis pathway in the zebrafish [J].
Eimon, P. M. ;
Kratz, E. ;
Varfolomeev, E. ;
Hymowitz, S. G. ;
Stern, H. ;
Zha, J. ;
Ashkenazi, A. .
CELL DEATH AND DIFFERENTIATION, 2006, 13 (10) :1619-1630
[9]
Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways [J].
Fukuda, S ;
Mantel, CR ;
Pelus, LM .
BLOOD, 2004, 103 (01) :120-127
[10]
Differential requirements for survivin in hematopoietic cell development [J].
Gurbuxani, S ;
Xu, YF ;
Keerthivasan, G ;
Wickrema, A ;
Crispino, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (32) :11480-11485